Roxbury, CT, United States of America

James Kocsis

This inventor holds 1 USPTO granted patent. Top assignee: Cornell University. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: James Kocsis. Retrieved from https://idiyas.com/inventor/james-kocsis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: James Kocsis: Inventor in Serotonin-System Treatment Research

Introduction

James Kocsis is an inventor associated with Cornell University and based in Roxbury, Connecticut. His patent work concerns a method for assessing whether patients may be susceptible or resistant to treatments that activate the brain’s serotonin system.

Latest Patents

Kocsis is named on 1 patent: “Method for Determining Sensitivity or Resistance to Compounds That Activate the Brain Serotonin System.” The invention describes assessing a patient’s age group and whether the patient carries a BDNF allele with a genetic alteration, then using those factors to correlate with likely treatment response. Under the method, a pre-adult patient with the alteration is correlated with susceptibility, a transition-age patient may be correlated with susceptibility or resistance, and an adult patient is correlated with resistance.

Career Highlights

Kocsis’s listed patent reflects research at the intersection of genetics, age-related factors, and potential responses to serotonin-system treatments. The method aims to support treatment-response assessment for conditions that may be treated with compounds activating this system.

Collaborations

The provided information identifies Francis S. Lee and Kevin Bath as Kocsis’s coworkers. His company affiliation is Cornell University.

Conclusion

James Kocsis’s patent focuses on using age group and a BDNF genetic alteration to help assess potential responses to compounds that activate the brain serotonin system.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…